ELEDON PHARMACEUTICALS INC (ELDN) Stock Earnings & Estimates
USA - NASDAQ:ELDN - US28617K1016 - Common Stock
2.25 USD
+0.19 (+9.22%)
2.24 USD
-0.01 (-0.44%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 1,266.99% | N/A 115.81% | N/A 42.89% | N/A 60.15% | ||||||||||||
| EBITDA YoY % growth | -23.44M | -45.15M -92.62% | -37.95M 15.95% | -13.1M 65.48% | -14.05M -7.25% | -14.17M -0.85% | -16.18M -14.18% | -36.87M -127.87% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -23.46M | -45.26M -92.92% | -38.12M 15.78% | -13.12M 65.58% | -14.06M -7.16% | -14.18M -0.85% | -16.19M -14.17% | -36.87M -127.73% | -39.78M -7.89% | -43M -8.09% | -70.577M -64.13% | N/A -29.94% | N/A -12.07% | N/A -13.27% | N/A -28.77% | N/A 17.23% | N/A 29.19% | N/A 54.06% | N/A 180.34% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -325.62 44.09% | -273.78 15.92% | N/A 85.58% | -28.08 28.86% | -22.86 18.59% | -13.21 42.22% | -2.32 82.43% | -2.76 -18.97% | -1.79 35.14% | -1.05 41.34% | N/A 17.57% | N/A -24.92% | N/A -1.89% | N/A -3.24% | N/A 39.46% | N/A 43.70% | N/A -68.42% | N/A 21.88% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 20.31% | -0.25 -137.19% | -0.27 -231.50% | -0.27 -106.61% | -0.23 9.33% | -0.23 7.21% | -0.23 11.54% | -0.26 5.06% | -0.27 -14.70% | -0.28 -19.12% |
| Revenue Q2Q % growth | ||||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.014M -17.08% | -25.271M -2.33% | -23.715M -32.01% | -24.608M 0.51% | -22.95M 4.43% | -23.843M 5.65% | -24.48M -3.23% | -25.755M -4.66% | -27.03M -17.78% | -28.305M -18.72% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.13 87.74% | -0.23 | 0.10 | 44.59% |
| Q1 2025 Q2Q % growth | -0.08 76.47% | -0.31 | 0.23 | 74.14% |
| Q4 2024 Q2Q % growth | 0.67 331.03% | -0.32 | 0.99 | 306.56% |
| Q3 2024 Q2Q % growth | -0.32 8.57% | -0.32 | 0.00 | 0.40% |
| Q2 2024 Q2Q % growth | -1.06 -165.00% | -0.31 | -0.75 | -242.52% |
| Q1 2024 Q2Q % growth | -0.34 54.67% | -0.37 | 0.03 | 8.80% |
| Q4 2023 Q2Q % growth | -0.29 57.97% | -0.40 | 0.11 | 27.47% |
| Q3 2023 Q2Q % growth | -0.35 52.05% | -0.47 | 0.12 | 25.49% |
| Q2 2023 Q2Q % growth | -0.40 38.46% | -0.47 | 0.07 | 14.53% |
| Q1 2023 Q2Q % growth | -0.75 -8.70% | -0.61 | -0.14 | -22.75% |
| Q4 2022 Q2Q % growth | -0.69 -16.95% | -0.72 | 0.03 | 3.53% |
| Q3 2022 Q2Q % growth | -0.73 -10.61% | -0.69 | -0.04 | -5.25% |
| Q2 2022 Q2Q % growth | -0.65 -30.00% | -0.72 | 0.07 | 9.48% |
| Q1 2022 Q2Q % growth | -0.69 -21.05% | -0.69 | 0.00 | 0.15% |
| Q4 2021 Q2Q % growth | -0.59 72.14% | -0.77 | 0.18 | 22.88% |
| Q3 2021 Q2Q % growth | -0.66 88.02% | -0.66 | 0.00 | -0.16% |
| Q2 2021 Q2Q % growth | -0.50 76.85% | -0.58 | 0.08 | 13.62% |
| Q1 2021 Q2Q % growth | -0.57 83.33% | -0.33 | -0.24 | -74.63% |
| Q4 2020 Q2Q % growth | -2.12 34.63% | -1.42 | -0.70 | -49.03% |
| Q3 2020 Q2Q % growth | -5.51 -39.14% | -1.78 | -3.73 | -209.27% |
| Q2 2020 Q2Q % growth | -2.16 65.71% | -3.03 | 0.87 | 28.70% |
| Q1 2020 Q2Q % growth | -3.42 63.46% | -2.94 | -0.48 | -16.42% |
| Q4 2019 Q2Q % growth | -3.24 | -4.77 | 1.53 | 32.13% |
| Q3 2019 Q2Q % growth | -3.96 | -7.44 | 3.48 | 46.74% |
| Q2 2019 Q2Q % growth | -6.30 | -7.80 | 1.50 | 19.26% |
| Q1 2019 Q2Q % growth | -9.36 | -8.90 | -0.46 | -5.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1.13% | 0% | 5.45% |
| Revenue | N/A | N/A | N/A | N/A |